Central Nervous System Uptake of Anti-CD8+ T Cell Minibodies in Multiple Sclerosis and Progressive Multifocal Leukoencephalopathy | MicrobiomeTrials← Back to trialsNCT05849467
Central Nervous System Uptake of Anti-CD8+ T Cell Minibodies in Multiple Sclerosis and Progressive Multifocal Leukoencephalopathy
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2023-10-19Est. Completion: 2030-04-01
Enrollment target: 15 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
Progressive Multifocal Leukoencephalopathy
Background:
Progressive multifocal leukoencephalopathy (PML) is a rare and often fatal brain infection caused by the JC…
Bethesda, United StatesEst. completion Dec 31, 2029
Progressive Multifocal Leukoencephalopathy
Background:
\- Progressive multifocal leukoencephalopathy (PML) is a severe viral infection of the brain. It is caused …
Bethesda, United StatesEst. completion Jan 1, 2052